Bocxman, You said: "Let's take $20 mil in revs, and 50 mil shares outstanding, and a biotech industry standard p/e of 30. That's .38 EPS, or $11.40/share!! Now let's discount back 20% for time/risk and we get $9.12/share"
when you say revenues,you mean earnings?Not clear enough.